Genertec Financial Statements From 2010 to 2025
| 5UM Stock | EUR 0.58 0.01 1.75% |
Check Genertec Universal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genertec Universal's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genertec financial statements analysis is a perfect complement when working with Genertec Universal Valuation or Volatility modules.
Genertec |
Genertec Universal Medical Company Current Valuation Analysis
Genertec Universal's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Genertec Universal Current Valuation | 7.33 B |
Most of Genertec Universal's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genertec Universal Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Genertec Universal Medical has a Current Valuation of 7.33 B. This is 62.03% lower than that of the Technology sector and 199.01% higher than that of the Health Information Services industry. The current valuation for all Germany stocks is 55.89% higher than that of the company.
Genertec Universal Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genertec Universal's current stock value. Our valuation model uses many indicators to compare Genertec Universal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genertec Universal competition to find correlations between indicators driving Genertec Universal's intrinsic value. More Info.Genertec Universal Medical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.24 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genertec Universal Medical is roughly 4.13 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genertec Universal's earnings, one of the primary drivers of an investment's value.About Genertec Universal Financial Statements
Genertec Universal stakeholders use historical fundamental indicators, such as Genertec Universal's revenue or net income, to determine how well the company is positioned to perform in the future. Although Genertec Universal investors may analyze each financial statement separately, they are all interrelated. For example, changes in Genertec Universal's assets and liabilities are reflected in the revenues and expenses on Genertec Universal's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Genertec Universal Medical. Please read more on our technical analysis and fundamental analysis pages.
Genertec Universal Medical Group Company Limited provides integrated healthcare services with integration of capital, technology, equipment, specialists, management, and training resources to hospital customers in Mainland China and Hong Kong. Genertec Universal Medical Group Company Limited was founded in 1984 and is headquartered in Beijing, China. GENERTEC UNIVER operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 705 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Genertec Stock
Genertec Universal financial ratios help investors to determine whether Genertec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Genertec with respect to the benefits of owning Genertec Universal security.